Board-certified endocrinologist and expert witness in peptide, anabolic, hormone and regenerative medicine. Independent review of the record, the standard of care, and the evidence behind the therapy — written to withstand cross-examination.
The Practice
Retained by plaintiff and defence counsel, insurers and regulatory bodies. Every engagement begins with the record and ends with an opinion I can defend under oath — no conclusion that the documents don’t support.
Clinic notes, compounding pharmacy records, lab panels and telehealth transcripts read in full and mapped onto a single timeline — prescriptions, dose changes, monitoring, consent and adverse events, each tied to its source page.
A written report measuring the care given against the guidelines and evidence that applied at the time — including where the field was genuinely unsettled, which in this specialty is often the decisive question.
Discovery and trial testimony, independent medical examinations, and an itemized list of the records still missing — the baselines never drawn, the panels never repeated, the encounters never disclosed.
Domain
A generalist expert flattens every case into the same shape. My practice is a single, fast-moving field — where the standard of care is contested, the agents are often compounded or off-label, and the record is scattered across clinics, pharmacies and telehealth providers.
BPC-157, TB-500, growth hormone secretagogues and compounded research peptides — agents prescribed well ahead of any approval or evidence base.
Read the full brief →Testosterone and TRT, GLP-1 agonists, estrogen and thyroid replacement, and adult growth hormone — measured against the guidelines in force at the time of care.
Read the full brief →Nandrolone, oxandrolone, stanozolol, ostarine and ligandrol — prescribed, compounded or simply supplied outside any approved indication.
Read the full brief →NAD+ protocols, stem cell applications and longevity interventions — where the marketing consistently outruns the evidence.
Read the full brief →Physician conduct measured against established guidelines and evolving evidence — including off-label, compounded and direct-to-consumer prescribing.
Read the full brief →Clinical decision support, autonomous prescribing workflows and AI-drafted records — where the algorithm advised, and who exercised judgment.
Read the full brief →
About
Dr. Fady Hannah-Shmouni is an Iraqi-Canadian internist, endocrinologist and clinician-investigator specializing in precision hormone medicine — and in the medicolegal questions that follow it into court.
Yale-trained and UBC faculty, he has served as an expert witness across Canada, the United States, and internationally — spanning medical malpractice, personal injury, and regulatory enforcement in peptide, hormone, regenerative and longevity medicine. He is the founder of Hormonaly.ai, the evidence engine that supports this work.
Peer-Reviewed Research
Pulled live from PubMed — the most recent indexed work, not a curated list.
Author & Educator
Built by Dr. Hannah-Shmouni
The evidence engine behind the practice — GRADE-rated, citation-verified answers to clinical questions in hormone, peptide and regenerative medicine.
Educational information only — not medical advice.
For expert review, opinion or testimony in a peptide, hormone, regenerative or longevity medicine matter.